Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SLV vs MRNA✓SelectedUSD · MRNASLV vs MRNA performance historyLatest closeAs of-2.19%11/13
Stock and ETF performance explorer

SLV vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+89.9%
MRNA return
-3.2%
Excess return
+93.1%
Maximum drawdown
-58.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.2%-3.4%+1.3%-2.0%
7D-5.8%-12.1%+6.3%-5.2%
30D-12.1%-1.3%-10.8%-12.1%
3M-24.1%+250.9%-275.1%-31.9%
6M-44.4%+343.0%-387.4%-51.3%
YTD-31.5%+657.4%-688.9%-42.1%
1Y-6.9%+794.9%-801.8%-22.2%
3Y+116.0%+218.1%-102.1%+84.6%
All+89.9%-3.2%+93.1%+67.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling